TG Therapeutics, Inc. (0VGI.L)

USD 31.97

(-5.69%)

Revenue Summary of TG Therapeutics, Inc.

  • TG Therapeutics, Inc.'s latest annual revenue in 2023 was 233.66 Million USD , up 8290.02% from previous year.
  • TG Therapeutics, Inc.'s latest quarterly revenue in 2024 Q2 was 73.46 Million USD , up 15.74% from previous quarter.
  • TG Therapeutics, Inc. reported a annual revenue of 2.78 Million USD in annual revenue 2022, down -58.36% from previous year.
  • TG Therapeutics, Inc. reported a annual revenue of 6.68 Million USD in annual revenue 2021, up 4300.66% from previous year.
  • TG Therapeutics, Inc. reported a quarterly revenue of 73.46 Million USD for 2024 Q2, up 15.74% from previous quarter.
  • TG Therapeutics, Inc. reported a quarterly revenue of 83.87 Million USD for 2024 Q3, up 14.17% from previous quarter.

Annual Revenue Chart of TG Therapeutics, Inc. (2023 - 1996)

Historical Annual Revenue of TG Therapeutics, Inc. (2023 - 1996)

Year Revenue Revenue Growth
2023 233.66 Million USD 8290.02%
2022 2.78 Million USD -58.36%
2021 6.68 Million USD 4300.66%
2020 152 Thousand USD 0.0%
2019 152 Thousand USD 0.0%
2018 152 Thousand USD -0.25%
2017 152.38 Thousand USD 0.0%
2016 152.38 Thousand USD 0.0%
2015 152.38 Thousand USD 0.0%
2014 152.38 Thousand USD 0.0%
2013 152.38 Thousand USD 699.98%
2012 19.04 Thousand USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD -100.0%
2002 500 Thousand USD -81.56%
2001 2.71 Million USD -49.39%
2000 5.35 Million USD 346.58%
1999 1.2 Million USD -60.0%
1998 3 Million USD 2900.0%
1997 100 Thousand USD 0.0%
1996 100 Thousand USD 0.0%

Peer Revenue Comparison of TG Therapeutics, Inc.

Name Revenue Revenue Difference
uniQure N.V. 15.84 Million USD -1374.86%
Abeona Therapeutics Inc. 3.5 Million USD -6576.057%
Aclaris Therapeutics, Inc. 31.24 Million USD -647.742%
Agilent Technologies, Inc. 6.83 Billion USD 96.58%
Agios Pharmaceuticals, Inc. 26.82 Million USD -771.126%
Alnylam Pharmaceuticals, Inc. 1.82 Billion USD 87.22%
Amicus Therapeutics, Inc. 399.35 Million USD 41.49%
Anavex Life Sciences Corp. - USD -Infinity%
Atara Biotherapeutics, Inc. 8.57 Million USD -2625.557%
Axsome Therapeutics, Inc. 270.6 Million USD 13.65%
BioMarin Pharmaceutical Inc. 2.41 Billion USD 90.341%
bluebird bio, Inc. 29.49 Million USD -692.155%
Blueprint Medicines Corporation 249.38 Million USD 6.303%
Cara Therapeutics, Inc. 20.96 Million USD -1014.374%
Imunon, Inc. - USD -Infinity%
Adicet Bio, Inc. - USD -Infinity%
Corcept Therapeutics Incorporated 482.37 Million USD 51.56%
Dynavax Technologies Corporation 232.28 Million USD -0.593%
Editas Medicine, Inc. 78.12 Million USD -199.095%
Emergent BioSolutions Inc. 1.04 Billion USD 77.732%
Esperion Therapeutics, Inc. 116.33 Million USD -100.854%
Exelixis, Inc. 1.83 Billion USD 87.233%
FibroGen, Inc. 147.75 Million USD -58.145%
Geron Corporation 237 Thousand USD -98491.561%
Halozyme Therapeutics, Inc. 829.25 Million USD 71.823%
Heron Therapeutics, Inc. 127.04 Million USD -83.922%
Illumina, Inc. 4.5 Billion USD 94.812%
Incyte Corporation 3.69 Billion USD 93.677%
Insmed Incorporated 305.2 Million USD 23.442%
Intellia Therapeutics, Inc. 36.27 Million USD -544.141%
Ionis Pharmaceuticals, Inc. 787.64 Million USD 70.334%
Iovance Biotherapeutics, Inc. 1.18 Million USD -19551.976%
IQVIA Holdings Inc. 14.98 Billion USD 98.441%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Mettler-Toledo International Inc. 3.78 Billion USD 93.832%
Evolus, Inc. 202.08 Million USD -15.626%
Myriad Genetics, Inc. 678.4 Million USD 65.557%
Neurocrine Biosciences, Inc. 1.88 Billion USD 87.618%
OPKO Health, Inc. 863.49 Million USD 72.94%
Sarepta Therapeutics, Inc. 1.24 Billion USD 81.207%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 61.538%
Verastem, Inc. - USD -Infinity%
Walgreens Boots Alliance, Inc. 147.65 Billion USD 99.842%
Waters Corporation 2.95 Billion USD 92.096%
Zoetis Inc. 8.54 Billion USD 97.265%
Vertex Pharmaceuticals Incorporated 9.86 Billion USD 97.632%
Thermo Fisher Scientific Inc. 42.85 Billion USD 99.455%
Biogen Inc. 9.83 Billion USD 97.624%
Sangamo Therapeutics, Inc. 176.23 Million USD -32.588%
Regeneron Pharmaceuticals, Inc. 13.11 Billion USD 98.219%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Homology Medicines, Inc. -6.65 Million USD 3613.186%
Nektar Therapeutics 90.12 Million USD -159.273%
Viking Therapeutics, Inc. - USD -Infinity%
Perrigo Company plc 4.65 Billion USD 94.981%
Unity Biotechnology, Inc. - USD -Infinity%